"topic","CS","lbf","pip","coef","name","id","database","accession","sub_category_code","organism","description_brief","top_genes"
"k1","L1","126.70","1.000","2.290","SHIN_B_CELL_LYMPHOMA_CLUSTER_9","M1393","MSigDB-C2",NA,"CGP","Mus musculus","Cluster 9 of genes distinguishing among different B lymphocyte neoplasms.","CD79A (13.047) CD19 (8.927) PAX5 (7.251) SPIB (6.733) CD40 (4.848) CXCR5 (3.053) IRF8 (0.745) REL (0.495) BCL11A (0.437) HMGB3 (-0.034)"
"k1","L2","127.54","1.000","2.567","HP_POSTERIOR_PHARYNGEAL_CLEFT","M36925","MSigDB-C5",NA,"HPO","Homo sapiens","Posterior pharyngeal cleft","MS4A1 (11.44) CD19 (8.927) TNFRSF13C (7.892) TNFRSF13B (7.771) CR2 (3.1) PRKCD (1.04) CD81 (0.983) NFKB2 (-0.337) TNFSF12 (-0.265) NFKB1 (-0.222)"
"k1","L3","43.44","1.000","0.722","GO_B_CELL_RECEPTOR_SIGNALING_PATHWAY","M16382","MSigDB-C5",NA,"GO:BP","Homo sapiens","A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. [GOC:add]","CD79A (13.047) MS4A1 (11.44) IGLL5 (11.209) BLK (9.06) CD19 (8.927) BLNK (7.385) PAX5 (7.251) CD79B (5.211) CD22 (4.243) MNDA (-4.029)"
"k1","L4","53.54","1.000","0.907","ZHAN_MULTIPLE_MYELOMA_CD2_UP","M18513","MSigDB-C2",NA,"CGP","Homo sapiens","Top 50 up-regulated genes in cluster CD-2 of multiple myeloma samples with the characteristic expression spike of CCND3 [GeneID=896].","CD79A (13.047) MS4A1 (11.44) VPREB3 (10.295) PNOC (8.05) TNFRSF13C (7.892) PAX5 (7.251) CD27 (-4.207) DTX1 (2.077) BEND5 (1.246) TRAF5 (1.072)"
"k1","L5","57.01","1.000","0.388","HADDAD_B_LYMPHOCYTE_PROGENITOR","M939","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in hematopoietic progenitor cells (HPC) of B lymphocyte lineage CD34+CD45RA+CD10+ [GeneID=947;5788;4311].","CD79A (13.047) MS4A1 (11.44) TCL1A (11.065) VPREB3 (10.295) BLK (9.06) CD19 (8.927) POU2AF1 (7.567) BLNK (7.385) PAX5 (7.251) TCL1B (6.442)"
"k1","L6","32.58","1.000","1.118","GO_IMMUNOGLOBULIN_BINDING","M17868","MSigDB-C5",NA,"GO:MF","Homo sapiens","Interacting selectively and non-covalently with an immunoglobulin. [GOC:ma]","MS4A1 (11.44) FCER2 (9.902) CD22 (4.243) FCGR2B (3.046) JCHAIN (1.643) FCGRT (0.12) LGALS3 (0.048) FCGR3A (0.038) LILRA2 (0.033) FCER1A (0.03)"
"k1","L7","28.96","0.970","0.641","HUTTMANN_B_CLL_POOR_SURVIVAL_DN","M12653","MSigDB-C2",NA,"CGP","Homo sapiens","Down-regulated genes in B-CLL (B-cell chronic leukemia) patients expressing high levels of ZAP70 and CD38 [GeneID=7535;952], which are associated with poor survival.","FCRL2 (7.254) BANK1 (6.31) CNTNAP2 (5.86) STAG3 (4.041) SOBP (3.028) COBLL1 (2.922) EAF2 (2.22) SLAMF1 (-1.715) ADARB1 (1.479) CASP1 (-1.447)"
"k1","L8","33.03","1.000","0.394","PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN","M17811","MSigDB-C2",NA,"CGP","Mus musculus","Genes down-regulated in post-GC, BCL6 [GeneID=604] dependent B cell non-Hodgkin's lymphoma (B-NHL) vs MYC [GeneID=4609] driven pre-GC lymphoma.","CD79A (13.047) VPREB3 (10.295) CD19 (8.927) FCRLA (8.831) NIBAN3 (8.138) PAX5 (7.251) BANK1 (6.31) EBF1 (5.815) KLHL14 (4.412) CD22 (4.243)"
"k1","L9","35.15","0.500","0.949","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","http://identifiers.org/reactome/R-HSA-983695","PC-reactome",NA,NA,NA,NA,"CD79A (13.047) BLK (9.06) CD19 (8.927) BLNK (7.385) CD79B (5.211) CD22 (4.243) BTK (0.991) DAPP1 (0.922) PLCG2 (0.717) PIK3CD (-0.707)"
"k1","L9","35.15","0.500","0.949","REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS","M601","MSigDB-C2",NA,"CP:REACTOME","Homo sapiens","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","CD79A (13.047) BLK (9.06) CD19 (8.927) BLNK (7.385) CD79B (5.211) CD22 (4.243) BTK (0.991) DAPP1 (0.922) PLCG2 (0.717) PIK3CD (-0.707)"
"k1","L10","33.53","0.998","-1.130","BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP","M15908","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in D-341 MED (OBR) cells (medulloblastoma) resistant to both carmustine and O6-BG [PubChem=2578;4578].","ID2 (-8.834) MT2A (-7.554) MT1X (-5.544) SGCE (3.745) LMO2 (-2.396) MT1F (-1.332) CA2 (-1.28) RABGAP1L (0.131) HSPA6 (0.045) FBXO21 (-0.042)"
"k2","L1","199.64","1.000","1.420","VERHAAK_AML_WITH_NPM1_MUTATED_UP","M4861","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in acute myeloid leukemia (AML) patients with mutated NPM1 [GeneID=4869].","FCN1 (13.551) CD14 (12.633) LGALS2 (12.581) TMEM176B (12.328) SERPINA1 (11.828) TMEM176A (10.894) G0S2 (10.657) VCAN (10.517) FPR1 (10.424) PILRA (9.732)"
"k2","L2","96.56","1.000","0.904","JAATINEN_HEMATOPOIETIC_STEM_CELL_DN","M6905","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.","S100A8 (15.45) S100A9 (15.438) FCN1 (13.551) CD14 (12.633) LGALS2 (12.581) MS4A6A (11.881) SERPINA1 (11.828) IGSF6 (11.507) S100A12 (10.967) CLEC10A (10.598)"
"k2","L3","105.81","1.000","1.807","LIAN_LIPA_TARGETS_3M","M16088","MSigDB-C2",NA,"CGP","Mus musculus","Genes up-regulated at 3 months of age in lungs from LIPA [GeneID=3988] knockout mice, which display pulmonary pathology.","S100A9 (15.438) MS4A6A (11.881) IGSF6 (11.507) CSTA (10.522) LILRB4 (9.731) MAFB (9.277) CLEC4E (9.229) MARCO (8.786) C1QA (8.719) C1QB (7.459)"
"k2","L4","132.08","1.000","1.047","GAL_LEUKEMIC_STEM_CELL_DN","M4502","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in leukemic stem cells (LSC), defined as CD34+CD38- [GeneID=947;952] cells from AML (acute myeloid leukemia patients) compared to the CD34+CD38+ cells.","S100A8 (15.45) S100A9 (15.438) FCN1 (13.551) CD14 (12.633) LGALS2 (12.581) MS4A6A (11.881) SERPINA1 (11.828) IGSF6 (11.507) S100A12 (10.967) G0S2 (10.657)"
"k2","L5","85.14","1.000","1.781","ZHENG_IL22_SIGNALING_UP","M1800","MSigDB-C2",NA,"CGP","Mus musculus","Genes up-regulated in ex-vivo colonic tissue after treatment with IL22 [GeneID=50616].","S100A8 (15.45) S100A9 (15.438) CD14 (12.633) CFD (12.519) MS4A6A (11.881) CSTA (10.522) THBD (6.357) RTN1 (5.824) HP (5.536) LRG1 (5.344)"
"k2","L6","78.49","1.000","1.702","ROSS_AML_WITH_CBFB_MYH11_FUSION","M5236","MSigDB-C2",NA,"CGP","Homo sapiens","Top 63 probe sets for pediatric acute myeloid leukemia (AML) subtype inv(16); has a CBFB-MYH11 fusion [GeneID=865;4629].","S100A8 (15.45) S100A9 (15.438) LGALS2 (12.581) CLEC10A (10.598) TGFBI (9.821) PLBD1 (9.152) MTMR11 (7.416) CLEC7A (7.162) CD1E (6.87) TNFAIP2 (6.15)"
"k2","L7","78.26","1.000","2.712","GO_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY","M26637","MSigDB-C5",NA,"GO:MF","Homo sapiens","Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species to initiate an innate immune response. [GOC:ar, GOC:bf, Wikipedia:Pattern_recognition_receptor]","FCN1 (13.551) CD14 (12.633) CLEC4E (9.229) MARCO (8.786) CLEC7A (7.162) TLR2 (6.302) CD36 (5.638) TLR8 (4.887) TLR4 (4.86) NOD2 (3.843)"
"k2","L8","45.05","1.000","3.041","GO_RAGE_RECEPTOR_BINDING","M18595","MSigDB-C5",NA,"GO:MF","Homo sapiens","Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products. [GOC:ai]","S100A8 (15.45) S100A9 (15.438) S100A12 (10.967) FPR1 (10.424) S100A4 (2.158) S100P (2.078) S100B (-1.913) HMGB1 (-0.781) S100A13 (0.314) HMGB2 (-0.211)"
"k2","L9","39.41","0.997","0.630","VERHAAK_GLIOBLASTOMA_MESENCHYMAL","M2122","MSigDB-C2",NA,"CGP","Homo sapiens","Genes correlated with mesenchymal type of glioblastoma multiforme tumors.","CD14 (12.633) SERPINA1 (11.828) CSTA (10.522) TGFBI (9.821) MAFB (9.277) PLBD1 (9.152) C5AR1 (8.648) STAB1 (8.597) HK3 (8.48) LILRB3 (8.302)"
"k2","L10","48.35","1.000","0.564","RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN","M8582","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in peripheral blood monocytes by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].","S100A9 (15.438) FCN1 (13.551) CD14 (12.633) CFD (12.519) MS4A6A (11.881) S100A12 (10.967) VCAN (10.517) FPR1 (10.424) LILRB4 (9.731) PID1 (9.377)"
"k3","L1","687.93","1.000","1.531","JAATINEN_HEMATOPOIETIC_STEM_CELL_UP","M15107","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.","SPINK2 (11.074) CYTL1 (10.244) SMIM24 (9.549) GIHCG (9.39) IGLL1 (8.858) GATA2 (8.858) CRHBP (8.753) CD34 (8.695) MYB (8.22) HPGDS (8.168)"
"k3","L2","67.44","1.000","1.089","ROSS_AML_OF_FAB_M7_TYPE","M4621","MSigDB-C2",NA,"CGP","Homo sapiens","Top 100 probe sets for pediatric acute myeloid leukemia (AML) subtype FAB M7 (also known as acute megakaryoblastic leukemia, AMKL).","GATA2 (8.858) GATA1 (7.482) KLF1 (6.651) TAL1 (6.311) TIMP3 (6.302) STXBP6 (5.571) FHL2 (5.384) PLOD2 (5.267) MYH10 (4.735) LAPTM4B (4.503)"
"k3","L3","87.25","1.000","0.842","TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP","M17275","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.","SPINK2 (11.074) SMIM24 (9.549) IGLL1 (8.858) HBD (8.474) HOXA9 (7.744) TPSAB1 (7.455) RBPMS (6.765) MYCT1 (6.7) CMBL (6.676) KLF1 (6.651)"
"k3","L4","64.54","1.000","-1.890","GO_MHC_PROTEIN_COMPLEX","M17090","MSigDB-C5",NA,"GO:CC","Homo sapiens","A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen. [GOC:add, GOC:jl, ISBN:0781735149, PMID:15928678, PMID:16153240]","HLA-F (-9.31) HLA-DQA1 (-4.977) HLA-DRB5 (-4.672) HLA-DRB1 (-4.295) HLA-DQA2 (-4.112) HLA-DPB1 (-2.855) HLA-DPA1 (-2.586) HLA-DRA (-2.185) HLA-C (-2.181) HLA-DMA (-2.158)"
"k3","L5","46.21","1.000","0.520","MULLIGHAN_MLL_SIGNATURE_1_DN","M18841","MSigDB-C2",NA,"CGP","Homo sapiens","The 'MLL signature 1': genes down-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.","CYTL1 (10.244) EGFL7 (9.163) MDK (8.539) HPGDS (8.168) NPR3 (7.746) TPSAB1 (7.455) DEPTOR (7.071) CAVIN1 (6.957) TFPI (6.772) RBPMS (6.765)"
"k3","L6","41.82","1.000","0.841","HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP","M17082","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in hematopoietic progenitor cells (HPC) of T lymphocyte and NK (natural killer) lineage.","CRHBP (8.753) MDK (8.539) NPR3 (7.746) CAVIN1 (6.957) PBX1 (6.552) TAL1 (6.311) TIMP3 (6.302) HTR1F (5.811) PLOD2 (5.267) HLA-DQA1 (-4.977)"
"k3","L7","36.70","1.000","1.539","TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP","M7176","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated by RUNX1-RUNX1T1 [GeneID=861;862] fusion protein in normal hematopoietic progenitors; their expression was sustained in subsequently developing monocytes.","CRHBP (8.753) HPGDS (8.168) TFPI (6.772) SOX4 (5.574) UCHL1 (4.983) TM4SF1 (4.897) QPRT (1.983) ARG2 (1.859) PPFIBP1 (1.414) NAP1L1 (0.893)"
"k3","L8","26.32","0.976","-0.999","FARMER_BREAST_CANCER_CLUSTER_1","M15015","MSigDB-C2",NA,"CGP","Homo sapiens","Cluster 1: interferon, T and B lymphocyte genes clustered together across breast cancer samples.","CD48 (-10.79) OAS1 (-2.621) JCHAIN (-1.643) CYTIP (-1.627) MX1 (-1.534) MZB1 (-0.974) CD38 (-0.648) FKBP11 (-0.63) OAS2 (-0.565) ISG15 (0.404)"
"k3","L9","28.87","0.967","0.479","GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP","M3155","MSigDB-C2",NA,"CGP","Homo sapiens","Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.","HBD (8.474) HPGDS (8.168) TPSAB1 (7.455) CPA3 (6.921) TYMS (6.683) KLF1 (6.651) PCLAF (6.302) DNAJC12 (5.627) MS4A3 (5.177) HBB (4.807)"
"k3","L10","30.75","1.000","-1.031","AMIT_EGF_RESPONSE_40_HELA","M4204","MSigDB-C2",NA,"CGP","Homo sapiens","Genes whose expression peaked at 40 min after stimulation of HeLa cells with EGF [GeneID=1950].","JUNB (-10.904) KLF2 (-9.784) SLC2A3 (-6.871) DUSP2 (-5.004) CEBPB (-1.798) IER2 (-1.735) HES1 (1.101) PTGS2 (-1.098) JUN (-0.845) KLF6 (-0.76)"
"k4","L1","790.73","1.000","3.545","HAHTOLA_SEZARY_SYNDROM_DN","M18968","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in monocytes isolated from peripheral blood samples of Sezary syndrom patients compared to those from healthy normal donors.","GNLY (15.399) NKG7 (14.09) GZMB (12.684) KLRD1 (10.688) KLRC1 (10.487) KLRF1 (10.469) XCL1 (9.678) CD160 (9.626) IL18RAP (7.633) SPON2 (7.373)"
"k4","L2","120.43","1.000","2.217","GO_CYTOLYSIS","M15834","MSigDB-C5",NA,"GO:BP","Homo sapiens","The rupture of cell membranes and the loss of cytoplasm. [UniProtKB-KW:KW-0204]","GZMA (13.153) GZMB (12.684) PRF1 (11.891) GZMH (11.556) GZMM (1.633) APOL1 (1.427) C8G (0.951) TGFB1 (0.844) ROMO1 (-0.233) MICA (0.05)"
"k4","L3","120.78","1.000","1.813","ONO_AML1_TARGETS_UP","M1977","MSigDB-C2",NA,"CGP","Mus musculus","Genes up-regulated in CD4+ [GeneID=920] T lymphocytes by expression of AML1 [GeneID=861] off a viral vector.","NKG7 (14.09) GZMA (13.153) GZMB (12.684) IFNG (7.959) FASLG (6.93) EOMES (6.451) CD244 (2.431) CCNF (1.427) SLAMF7 (1.318) HAVCR2 (0.742)"
"k4","L4","107.92","1.000","0.487","DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN","M12570","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in T-PLL cells (T-cell prolymphocytic leukemia) bearing the inv(14)/t(14:14) chromosomal aberration.","GNLY (15.399) NKG7 (14.09) GZMA (13.153) GZMB (12.684) PRF1 (11.891) GZMH (11.556) CST7 (11.488) KLRD1 (10.688) KLRC1 (10.487) KLRF1 (10.469)"
"k4","L6","88.53","1.000","0.525","JAATINEN_HEMATOPOIETIC_STEM_CELL_DN","M6905","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.","GNLY (15.399) NKG7 (14.09) GZMA (13.153) GZMB (12.684) FGFBP2 (12.122) PRF1 (11.891) GZMH (11.556) CST7 (11.488) KLRC1 (10.487) KLRF1 (10.469)"
"k4","L7","28.69","1.000","-0.940","KAMIKUBO_MYELOID_CEBPA_NETWORK","M2092","MSigDB-C2",NA,"CGP","Mus musculus","Network of differentially expressed myeloid genes centered around CEBPA [GeneID=1050].","SPINT2 (-8.172) IRF8 (-3.101) RAB31 (-2.583) IL18 (-1.587) LGALS1 (1.323) CEBPA (-0.732) ANXA1 (0.464) SERPINB1 (0.399) ITGAM (0.064) ALDH2 (0.055)"
"k4","L9","41.42","1.000","1.774","BIOCARTA_SET_PATHWAY","M3075","MSigDB-C2",NA,"CP:BIOCARTA","Homo sapiens","Granzyme A mediated Apoptosis Pathway","GZMA (13.153) GZMB (12.684) PRF1 (11.891) HMGB2 (0.211) APEX1 (-0.13) SET (-0.082) DFFB (-0.046) DFFA (0.012) CREBBP (0.006) ANP32A (-0.004)"
"k4","L5","83.46","0.500","1.250","Graft-versus-host disease","83124","BioSystems-kegg","hsa05332",NA,NA,NA,"GZMB (12.684) PRF1 (11.891) KLRD1 (10.688) KLRC1 (10.487) IFNG (7.959) FASLG (6.93) KIR3DL1 (5.894) KIR2DL3 (5.853) KIR3DL2 (5.824) HLA-DPB1 (3.348)"
"k4","L5","83.46","0.500","1.250","KEGG_GRAFT_VERSUS_HOST_DISEASE","M13519","MSigDB-C2",NA,"CP:KEGG","Homo sapiens","Graft-versus-host disease","GZMB (12.684) PRF1 (11.891) KLRD1 (10.688) KLRC1 (10.487) IFNG (7.959) FASLG (6.93) KIR3DL1 (5.894) KIR2DL3 (5.853) KIR3DL2 (5.824) HLA-DPB1 (3.348)"
"k4","L10","25.80","0.577","1.294","GO_REGULATION_OF_T_CELL_CHEMOTAXIS","M10473","MSigDB-C5",NA,"GO:BP","Homo sapiens","Any process that modulates the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus. [GOC:dph, GOC:tb]","XCL2 (9.815) XCL1 (9.678) STK39 (1.874) TNFSF14 (1.36) ADAM10 (0.597) OXSR1 (0.1) TMEM102 (0.078) WNK1 (0.055) CCL27 (-0.033) CCR2 (0.022)"
"k4","L10","25.80","0.397","1.288","GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS","M24920","MSigDB-C5",NA,"GO:BP","Homo sapiens","Any process that activates or increases the frequency, rate or extent of lymphocyte chemotaxis. [PMID:19255442]","XCL2 (9.815) XCL1 (9.678) STK39 (1.874) TNFSF14 (1.36) ADAM10 (0.597) OXSR1 (0.1) PTK2B (-0.083) TMEM102 (0.078) WNK1 (0.055) CCL27 (-0.033)"
"k4","L8","26.59","0.817","1.496","GO_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION","M23801","MSigDB-C5",NA,"GO:BP","Homo sapiens","Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell proliferation. [GOC:ai]","XCL1 (9.678) LGALS9B (6.205) LGALS9C (4.598) VSIR (0.956) LGALS9 (0.303) ZBTB7B (-0.213) TNFRSF14 (-0.123) ARG2 (0.035) TWSG1 (0.012) CD274 (-0.007)"
"k4","L8","26.59","0.182","0.858","GO_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","M15747","MSigDB-C5",NA,"GO:BP","Homo sapiens","Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell activation. [GOC:obol]","XCL1 (9.678) TBX21 (8.73) LGALS9B (6.205) LGALS9C (4.598) RUNX3 (2.076) VSIR (0.956) RC3H1 (0.745) RUNX1 (-0.53) ANXA1 (0.464) IL4R (0.335)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0100356","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111853","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111854","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111858","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111860","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111862","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111864","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111870","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111871","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111872","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111873","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111874","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0111875","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0112609","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0119294","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0119302","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0119303","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0119304","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L1","481.95","0.053","-1.802","Protein Synthesis","http://identifiers.org/smpdb/SMP0119305","PC-pathbank",NA,NA,NA,NA,"RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS24 (-9.982) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) RPL39 (-6.754) RPS29 (-5.931) RPS28 (-4.451)"
"k5","L2","83.62","1.000","1.576","BIOCARTA_CTLA4_PATHWAY","M1467","MSigDB-C2",NA,"CP:BIOCARTA","Homo sapiens","The Co-Stimulatory Signal During T-cell Activation","CD3D (12.012) CD3E (10.276) CD28 (7.581) ICOS (6.331) CD3G (5.24) CTLA4 (5.21) ITK (1.929) LCK (1.394) CD247 (-1.37) ICOSLG (0.464)"
"k5","L3","92.75","1.000","-0.987","DAZARD_UV_RESPONSE_CLUSTER_G1","M9375","MSigDB-C2",NA,"CGP","Homo sapiens","Cluster G1: genes most highly up-regulated in NHEK cells (normal keratinocyte) between 6 h and 12 h after UV-B irradiation.","RPL37A (-10.56) RPL34 (-10.401) RPL38 (-10.198) RPS21 (-9.883) RPL37 (-9.818) RPL36A (-7.613) UQCRB (-2.994) RPL31 (-2.694) RPS23 (-2.69) COX7C (-1.631)"
"k5","L4","45.20","0.980","1.719","HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS","M38640","MSigDB-C5",NA,"HPO","Homo sapiens","Decreased proportion of CD3-positive T cells","CD3D (12.012) CD3E (10.276) IL7R (6.124) CD247 (-1.37) PNP (0.487) IL2RG (0.267) PGM3 (0.104) RAG1 (-0.048) RAG2 (-0.039) DCLRE1C (-0.004)"
"k5","L5","33.32","1.000","0.328","JAATINEN_HEMATOPOIETIC_STEM_CELL_DN","M6905","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.","CD3D (12.012) MAL (10.094) AQP3 (9.742) CD5 (8.615) LEF1 (8.589) TRAT1 (8.276) ADTRP (7.933) CAMK4 (7.875) CD28 (7.581) FBLN7 (6.509)"
"k5","L8","43.11","0.997","0.929","GO_INTERLEUKIN_4_PRODUCTION","M23121","MSigDB-C5",NA,"GO:BP","Homo sapiens","The appearance of interleukin-4 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. [GOC:mah]","CD3E (10.276) LEF1 (8.589) CD40LG (8.513) CD28 (7.581) FOXP3 (5.841) ITK (1.929) NDFIP1 (1.321) GATA3 (1.068) NLRP3 (-0.737) IRF4 (0.721)"
"k5","L9","30.42","0.993","0.342","LEE_DIFFERENTIATING_T_LYMPHOCYTE","M2200","MSigDB-C2",NA,"CGP","Homo sapiens","Genes enriched at every T lymphocyte differentiation stage compared to the early passage fetal thymic stromal cultures (TSC).","CD3D (12.012) MAL (10.094) AQP3 (9.742) LEF1 (8.589) TRAT1 (8.276) UBASH3A (6.837) ICOS (6.331) IL7R (6.124) CD3G (5.24) BTG2 (2.23)"
"k5","L10","48.89","1.000","0.677","BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES","M2328","MSigDB-C2",NA,"CGP","Mus musculus","Genes translationally regulated in MEF cells (embryonic fibroblasts) in response to serum starvation and by rapamycin (sirolimus) [PubChem=6610346].","RPS24 (-9.982) RPL36A (-7.613) RPL23 (-3.427) RPS23 (-2.69) RPL26 (-1.823) FAU (-1.29) RPL27A (-0.911) RPL24 (-0.831) RPS9 (-0.689) RPL28 (-0.669)"
"k5","L6","39.13","0.829","0.835","SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN","M8813","MSigDB-C2",NA,"CGP","Homo sapiens","Top 50 down-regulated markers distinguishing diffuse large B-cell lymphoma (DLBCL) from follicular lymphoma (FL) samples.","CD3D (12.012) CD3E (10.276) CD40LG (8.513) TNFRSF25 (4.116) PDCD1 (3.675) ST8SIA1 (2.789) CLU (-1.87) PIK3IP1 (1.564) LY9 (1.472) HSPA1L (1.36)"
"k5","L6","39.13","0.171","1.441","GO_T_CELL_TOLERANCE_INDUCTION","M22263","MSigDB-C5",NA,"GO:BP","Homo sapiens","A process involving any mechanism for tolerance induction in T cells. [GOC:jal, ISBN:0781735149, PMID:16551263]","CD3E (10.276) ICOS (6.331) FOXP3 (5.841) IL2RA (2.29) AIRE (0.794) PHLPP1 (-0.074) CLC (-0.032) LILRB2 (-0.031) IDO1 (-0.031) HLA-B (0.011)"
"k5","L7","32.63","0.826","1.099","LEE_NAIVE_T_LYMPHOCYTE","M12367","MSigDB-C2",NA,"CGP","Homo sapiens","Genes enriched in the naive circulating T lymphocytes compared to the earlier differentiation stages.","ADTRP (7.933) VSIG1 (5.498) PCED1B (2.5) INPP4B (2.241) GIMAP5 (1.867) LDLRAP1 (1.419) PASK (1.172) SHISAL2A (1.03) TAGAP (0.84) PLEKHA1 (-0.655)"
"k5","L7","32.63","0.174","1.476","GO_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH","M26486","MSigDB-C5",NA,"GO:MF","Homo sapiens","The action of a molecule that contributes to the structural integrity of the myelin sheath of a nerve. [GOC:mah]","MAL (10.094) PLLP (4.431) CMTM8 (1.826) PLP1 (-0.04) MOBP (-0.038) MALL (-0.038) NCMAP (-0.019) MARVELD1 (-0.019) MBP (0) MAL2 (0)"
"k6","L1","184.87","1.000","-0.637","HSIAO_HOUSEKEEPING_GENES","M11197","MSigDB-C2",NA,"CGP","Homo sapiens","Housekeeping genes identified as expressed across 19 normal tissues.","CLIC1 (-10.618) ACTB (-10.377) GAPDH (-9.641) ACTG1 (-9.641) TAGLN2 (-8.888) DYNLL1 (-8.203) PFN1 (-7.969) YWHAH (-7.004) UBC (-6.071) LDHA (-6.026)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0100356","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111853","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111854","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111858","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111860","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111862","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111864","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111870","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111871","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111872","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111873","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111874","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0111875","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0112609","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0119294","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0119302","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0119303","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0119304","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L2","132.22","0.053","1.184","Protein Synthesis","http://identifiers.org/smpdb/SMP0119305","PC-pathbank",NA,NA,NA,NA,"RPL22 (1.378) RPS25 (1.133) RPL32 (1.112) RPL21 (1.102) RPS14 (1.071) RPS16 (0.914) RPS12 (0.897) RPLP2 (0.861) RPS6 (0.827) RPS18 (0.824)"
"k6","L3","71.19","1.000","-0.464","TARTE_PLASMA_CELL_VS_PLASMABLAST_DN","M19745","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in mature plasma cells compared with plasmablastic B lymphocytes.","CLIC1 (-10.618) HMGB2 (-7.677) GLIPR1 (-7.574) YWHAH (-7.004) LSP1 (-6.888) TBCB (-6.006) PPP4C (-5.838) GET3 (-5.041) ATP1B3 (-4.854) VDAC1 (-4.829)"
"k6","L4","75.26","1.000","-0.422","REN_ALVEOLAR_RHABDOMYOSARCOMA_DN","M19541","MSigDB-C2",NA,"CGP","Homo sapiens","Genes commonly down-regulated in human alveolar rhabdomyosarcoma (ARMS) and its mouse model overexpressing PAX3-FOXO1 [GeneID=5077;2308] fusion.","CLIC1 (-10.618) KLF6 (-9.304) TAGLN2 (-8.888) TPM4 (-7.752) GLIPR1 (-7.574) ANXA5 (-6.11) SH3BGRL3 (-5.702) ARHGDIA (-5.563) RHOC (-5.49) UBE2A (-5.421)"
"k6","L5","64.15","1.000","-1.203","WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER","M39740","MSigDB-C2",NA,"CP:WIKIPATHWAYS","Homo sapiens","Metabolic reprogramming in colon cancer","GAPDH (-9.641) PKM (-6.651) LDHA (-6.026) SHMT2 (-4.338) PFKL (-4.055) IDH2 (-3.831) SDHB (-3.036) SLC1A5 (-2.992) ENO1 (-2.88) TALDO1 (-2.671)"
"k6","L6","57.52","1.000","-1.178","GNATENKO_PLATELET_SIGNATURE","M15669","MSigDB-C2",NA,"CGP","Homo sapiens","Top 50 most up-regulated genes in human platelet cells.","ACTB (-10.377) CD99 (-9.328) TAGLN2 (-8.888) DYNLL1 (-8.203) YWHAH (-7.004) PKM (-6.651) UBC (-6.071) H3-3A (-3.005) CFL1 (-2.232) MYL6 (-1.881)"
"k6","L7","62.80","0.333","-1.083","Pathogenic Escherichia coli infection","83103","BioSystems-kegg","hsa05130",NA,NA,NA,"ACTB (-10.377) ACTG1 (-9.641) TUBA1B (-8.67) TUBB4B (-6.984) ITGB1 (-4.76) ARPC2 (-4.65) ARPC1B (-4.145) RHOA (-4) ARPC4 (-2.586) ARPC3 (-2.379)"
"k6","L7","62.80","0.333","-1.083","KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION","M2333","MSigDB-C2",NA,"CP:KEGG","Homo sapiens","Pathogenic Escherichia coli infection","ACTB (-10.377) ACTG1 (-9.641) TUBA1B (-8.67) TUBB4B (-6.984) ITGB1 (-4.76) ARPC2 (-4.65) ARPC1B (-4.145) RHOA (-4) ARPC4 (-2.586) ARPC3 (-2.379)"
"k6","L7","62.80","0.333","-1.083","WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION","M39613","MSigDB-C2",NA,"CP:WIKIPATHWAYS","Homo sapiens","Pathogenic Escherichia coli infection","ACTB (-10.377) ACTG1 (-9.641) TUBA1B (-8.67) TUBB4B (-6.984) ITGB1 (-4.76) ARPC2 (-4.65) ARPC1B (-4.145) RHOA (-4) ARPC4 (-2.586) ARPC3 (-2.379)"
"k6","L8","44.47","0.998","-0.841","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP","M7488","MSigDB-C2",NA,"CGP","Homo sapiens","Antigen processing and presentation genes up-regulated in JY cells (B lymphocytes) treated with TSA [PubChem=5562].","TBCB (-6.006) PSMC4 (-4.785) COPE (-3.859) TMED9 (-3.729) HERPUD1 (-3.139) PDIA3 (-2.937) KDELR2 (-2.879) PSMD4 (-2.64) PSMD13 (-2.555) TXNDC12 (-2.413)"
"k6","L9","44.21","1.000","-0.490","YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17","M2336","MSigDB-C2",NA,"CGP","Mus musculus","Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 17.","ACTB (-10.377) TPM4 (-7.752) PSMD8 (-5.044) POLR3K (-4.546) COPE (-3.859) NDUFV2 (-3.847) ERH (-3.218) PSMA7 (-3.154) SDHB (-3.036) EIF4A3 (-2.907)"
"k6","L10","46.96","0.256","-0.353","MULLIGHAN_MLL_SIGNATURE_1_UP","M17856","MSigDB-C2",NA,"CGP","Homo sapiens","The 'MLL signature 1': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.","DYNLL1 (-8.203) S100A4 (-7.235) PKM (-6.651) ARL6IP5 (-6.506) LCP1 (-5.847) MYO1F (-5.611) PRDX1 (-4.663) ARPC2 (-4.65) ARPC1B (-4.145) PYCARD (-4.098)"
"k6","L10","46.96","0.744","-0.442","RICKMAN_METASTASIS_DN","M12369","MSigDB-C2",NA,"CGP","Homo sapiens","Genes down-regulated in metastatic vs non-metastatic HNSCC (head and neck squamous cell carcinoma) samples.","TAGLN2 (-8.888) TPM4 (-7.752) JPT1 (-7.67) RHOG (-6.776) PKM (-6.651) MYO1G (-6.131) SH3BGRL3 (-5.702) CAP1 (-5.189) GET3 (-5.041) IFI16 (-4.616)"
